Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer

Charline Ogier, Christel Larbouret, Nelly Pirot et al.|Cancer Letters|2018

Cited by 57